VANGUARD GROUP INC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$155,637,437
-61.2%
9,636,993
-0.3%
0.00%
-60.0%
Q2 2023$401,063,718
-31.4%
9,664,186
-0.6%
0.01%
-33.3%
Q1 2023$584,438,895
-16.5%
9,717,973
+1.8%
0.02%
-21.1%
Q4 2022$700,297,096
+11.9%
9,547,336
+15.9%
0.02%
+5.6%
Q3 2022$625,986,000
+11.1%
8,238,835
+1.6%
0.02%
+12.5%
Q2 2022$563,627,000
-14.9%
8,109,739
+1.4%
0.02%0.0%
Q1 2022$662,609,000
+11.8%
7,997,688
+1.3%
0.02%
+23.1%
Q4 2021$592,629,000
-35.1%
7,893,313
+0.4%
0.01%
-43.5%
Q3 2021$913,312,000
-47.3%
7,861,860
+0.7%
0.02%
-46.5%
Q2 2021$1,732,220,000
+56.1%
7,809,123
-7.0%
0.04%
+43.3%
Q1 2021$1,109,886,000
-22.2%
8,396,783
+1.9%
0.03%
-26.8%
Q4 2020$1,426,536,000
+56.2%
8,243,970
+0.4%
0.04%
+36.7%
Q3 2020$913,551,000
+106.1%
8,207,262
+9.8%
0.03%
+87.5%
Q2 2020$443,244,000
-11.3%
7,474,620
+0.8%
0.02%
-23.8%
Q1 2020$499,545,000
-18.3%
7,418,256
+2.3%
0.02%0.0%
Q4 2019$611,242,000
+17.8%
7,253,370
+4.5%
0.02%
+10.5%
Q3 2019$518,997,000
+33.2%
6,940,317
+12.6%
0.02%
+26.7%
Q2 2019$389,565,000
+28.0%
6,161,088
-2.5%
0.02%
+25.0%
Q1 2019$304,240,000
+41.6%
6,315,973
-1.6%
0.01%
+20.0%
Q4 2018$214,908,000
-24.4%
6,418,965
+18.3%
0.01%
-9.1%
Q3 2018$284,265,000
+83.5%
5,424,908
+9.6%
0.01%
+83.3%
Q2 2018$154,881,000
+47.1%
4,948,273
+2.4%
0.01%
+20.0%
Q1 2018$105,298,000
+13.2%
4,830,158
+4.9%
0.01%
+25.0%
Q4 2017$93,042,000
+4.7%
4,606,070
+2.8%
0.00%0.0%
Q3 2017$88,897,000
+20.0%
4,478,442
+4.5%
0.00%0.0%
Q2 2017$74,111,000
+200.2%
4,283,862
+40.5%
0.00%
+300.0%
Q1 2017$24,688,000
+15.5%
3,047,940
+12.0%
0.00%0.0%
Q4 2016$21,371,000
-4.2%
2,722,428
+4.2%
0.00%0.0%
Q3 2016$22,303,000
-18.9%
2,611,707
+10.8%
0.00%
-50.0%
Q2 2016$27,511,000
+8746.0%
2,357,427
+10863.8%
0.00%
Q1 2016$311,000
-37.9%
21,502
-3.9%
0.00%
Q4 2015$501,00022,3810.00%
Other shareholders
NOVOCURE LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders